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EBV-specific CD8+ T cells have previously shown to be present in high frequencies within the tonsil compared to the 
peripheral blood of healthy EBV carriers. The anatomical location of these EBV-specific CD8+ T cells in the tonsil is 
currently unknown and could be the means of identifying lytically infected cells. Class I tetramer staining can now be 
adapted for in-situ staining of EBV-specific CD8+ T cells.  
 
We have utilized Quantum dot (Qdot) nanocrystal technology to form EBV-specific Qdot multimers. Each multimer has a 
potential to form strong MHC-TCR interactions and are extremely photo stable. Here, we have optimized and validated the 
use of EBV-specific Qdot multimers in-situ staining  to visualize EBV-specific CD8+ T cells in  human tonsil sections 
from healthy EBV carriers.  
 
Saturation of streptavidin conjugated Qdot655 (StpQdot655) was achieved at a ratio of 3.9µg of MHC class I monomer to 
1pmol of StpQdot655 forming EBV-specific Qdot multimers. In all experiments EBV-specific Qdot multimers were shown 
to be extremely stable and demonstrated specific binding in flow cytometry and microscopy analysis. Qdot multimers also 
showed comparable staining intensity to conventional tetramers in flow cytometry analysis of multiple T cell populations. 
Optimized confocal microscope settings, using Qdot655 and Alexa488 reagents, allowed for the visualization of EBV-
specific CD8+ T cell clones using corresponding EBV-specific Qdot multimers and anti-CD8 Alexa 488 antibodies. 
 
The use of EBV-specific Qdot multimers in an optimized staining protocol has now been validated for the visualization of 
EBV-specific CD8+ T cell via confocal microscopy. Once an EBV+ HLA matched tonsil specimen can be obtained the 
localization of EBV-specific CD8+ T cells in the tonsil can for the first time be determined. 
 
 
ACKNOWLEGMENTS  
I would firstly like to especially thank my supervisor Andrew Hislop whose help, advice and 
guidance has been highly valued all through my project. 
I would also like to thank the following people who have provided much support in all 
aspects of my projects and without whom I would not of been able to conduct my 
experiments: 
 The T cell group for all your helpful knowledge and for welcoming me into your 
group and for providing t cell clones. 
 Patricia Laylor for helping me with the Krumdiek slicing of tonsils. 
 David Barber for all your last minute help with the Vibratome slicing of tonsils. 
 Andrew Bell for all your help with PCR analysis. 
 ENT surgeons and secretaries at the Birmingham Childrens hospital NHS trust, 
without their co operation we would not have obtained precious tonsil samples. 
 Medical Research Council for funding 
1 
 
TABLE OF CONTENTS  
 
 
1    INTRODUCTION...................................................................................................................…3 
1.1 Epstein-Barr virus (EBV) biology. ...................................................................................... 3 
1.2 EBV and Cancer. ................................................................................................................. 4 
1.3 T cell Immunity. .................................................................................................................. 5 
1.4 EBV targets of the T cell response. ..................................................................................... 5 
1.5 Anatomy of the tonsil. ......................................................................................................... 6 
1.6 Tetramer Technology .......................................................................................................... 7 
1.7 In situ Tetramer staining. ..................................................................................................... 8 
1.8 Qdot Multimer technology. ................................................................................................. 9 
1.9 Aims .................................................................................................................................. 10 
 
2 MATERIALS AND METHODS. ..............................................................................................11 
2.1 Human tissue specimens and PBMCs. .............................................................................. 11 
2.2 T cell clones ....................................................................................................................... 11 
2.3 Synthesis of Qdot multimers and PE tetramers. ................................................................ 11 
2.4 Staining of T cell clones for microscopic analysis. ........................................................... 12 
2.5 Immunofluorescence in situ staining of Tonsil ................................................................. 12 
2.6 Confocal and Epifluorescence microscopy ....................................................................... 13 
2.7 Flow cytometry .................................................................................................................. 13 
 
3 RESULTS. ..................................................................................................................................14 
3.1 Determination of the amount of MHC class I monomer required to be added 1µl of 1µM 
Qdot 655 to achieve optimal staining of a T cell clone with this reagent ..................................... 14 
3.2 Validation and titration of GLC Qdot vs. PBMCs from HLA A2EBV sero positive and 
sero negative donors and a GLC-specific T cell clone. ................................................................. 15 
3.3 Validation of Qdot multimer versus conventional PE tetramer staining of tonsillar 
Unfractionated Mononuclear (UM) populations. .......................................................................... 18 
3.4 Epifluorescence analysis of GLC-specific clone staining using the Qdot multimer. ........ 19 
3.5 Tissue staining with Qdot655 multimer, anti-CD8 and anti-CD20 and analysis by 
epifluorescence microscopy. ......................................................................................................... 22 
3.6 Optimisation of Confocal Microscopy using T cell clones stained with Qdot655 and 
Alexa488 labelled antibodies......................................................................................................... 25 
3.7 Determining if the Qdot multimers can be viewed using the optimised confocal 
configuration. ................................................................................................................................. 27 
3.8 In-situ staining of tonsil sections with Qdot mulitmers and confocal imaging. ................ 29 
 
4 DISCUSSION .............................................................................................................................33 
 
5 LIST OF REFERANCES...........................................................................................................37 
 
2 
 
LIST OF FIGURES 
 
Figure 1.1 schematic representation of EBV primary infection through to carrier and reactivation  
of the virus...........................................................................................................................................4 
 
Figure 1.2 Schematic representation of tonsil structure .....................................................................7 
 
Figure 1.3 Structure of Original Tetramer and Qdot Multimer ..........................................................9 
 
Figure 1.4 Emission spectra of Qdot dyes..........................................................................................10 
 
Figure 3.1 Saturation of Streptavidin conjugated Qdot with A2 GLC monomer .............................15 
 
Figure 3.2. Frequency of EBV-specific CD8+ T cells (a) GLC clone IM225.8, (b) PBMC’s of a 
Sero positive donor and (c) PBMCs of a Sero negative donor..........................................................17 
 
Figure 3.3 Validation of Qdot and PE tetramers vs. Tonsil Sample T26..........................................19 
 
Figure 3.4 – Epifluorescence microscopy of GLC clones..................................................................21 
 
Figure 3.5 – In-situ tissue staining of Tonsil (T43) and Flow cytometry GLC-PE tetramer staining 
of T43 UM’s.......................................................................................................................................24 
 
Figure 3.6 – Confocal images of GLC clones stained with different excitation fluorochromes........26 
 
Figure 3.7 – Confocal images of FLR-Q, CD8-Alexa488 and CD8-Q staining using FLR clones...28 
 
Figure 3.8 – Flow cytometry analysis of T48 UMs............................................................................29  
 
Figure 3.9 – Confocal images, validating Alexa488 and Qdot655 reagents for use in in-situ staining 
of the tonsil (T48)...............................................................................................................................31 
 
Figure 3.10 – Confocal images of combined antibody and tetramer in situ staining of T48.............32 
3 
 
1 INTRODUCTION 
1.1 Epstein-Barr virus (EBV) biology. 
 
EBV, a double stranded DNA virus, is a member of the herpesviridae family which chronically 
infects >90% of the world’s population. Infection with EBV occurs via saliva transmission usually 
in childhood which results in an asymptomatic infection. If primary infection is delayed into 
adolescence/adulthood infectious mononucleosis (IM) can result in 25% of infections(Crawford, 
Macsween et al. 2006). IM is an acute self limiting disease which presents with flu like symptoms 
characterised by a large expansion of CD8+ T cells specific for EBV, which has been shown to 
persist for months(Niederman, McCollum et al. 1968). IM patients have allowed for the study of 
primary infection and revealed what we know today about the early events of EBV infection.  
EBV enters the oropharynx and infects a permissive cell type of unknown identity but is most likely 
an epithelial cell of the oropharynx or a resting B cell.  EBV is known to establish infection in the B 
cells population of the oropharyngeal lymphoid tissue. Upon entry into the B cell (Li, Spriggs et al. 
1997) the viral genome traffics to the nucleus and circularises to form an episome and a restricted 
set of genes are expressed and transforms resting B cells to an immortalised latently infected 
lymphoblastoid cell. Following the B cell transformation process, viral gene expression is down 
regulated and the infected cells exit the lymphoid tissues as a long lived memory B cell (Figure 
1.1). The virus can then persist within its host for life as a latent infection with the infected B cells 
recirculating between the oropharyngeal lymphoid tissues and the blood.  
During transit through the oropharanyx latently infected EBV cells can spontaneously undergo 
reactivation into lytic cycle producing new virions. The identification of lytically infected cells has 
not been established fully, however, epithelial cells were thought to account for the detection of 
virus in throat washings of healthy infected individuals(Hutt-Fletcher 2005). Consistent with this, B 
cells in vitro were able to efficiently transfer surface bound EBV to  epithelial cells of the 
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oropharynx(Shannon-Lowe, Adland et al. 2009). Regardless, virus is shed into the oropharynx 
enabling transmission from host to host as new infection of B cells.  
 
 
 
1.2 EBV and Cancer. 
 
EBV was the first virus associated with human cancer and was discovered in Burkitt’s lymphoma, 
in which all cells contain EBV genome(Epstein, Achong et al. 1964). EBV has since been 
implicated in a number of B and epithelial cell malignancies. Approximately 40% of Hodgkin’s 
lymphoma in the developed world contains EBV (Deacon, Pallesen et al. 1993) as well as some T 
and natural killer (NK) cell lymphomas. Nasopharyngeal carcinoma (NPC) is an epithelial 
malignancy in which virtually all cases are EBV positive with a high incidence in China and South 
East Asia. Genetic or environmental factors such as immunosuppression or diet in an EBV positive 
individual can allow for the development of EBV associated malignancies (Young and Rickinson 
Figure 1.1 - schematic representation of EBV primary infection through to carrier and reactivation 
of the virus. (Hislop, Taylor et al. 2007) 
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2004). Cellular immunity is important in controlling EBV and when suppressed outgrowth of EBV 
transformed B cells can occur manifesting as post transplant lymphoproliferative disease 
(PTLD)(Haque, Wilkie et al. 2002) . 
1.3 T cell Immunity. 
 
Innate and adaptive immunity provide effective defence against pathogens and work together to 
eliminate an infectious agent. However it is the cells of the adaptive immune system that are able to 
form immune memory to pathogens and T lymphocytes are thought to be particularly important in 
the control of EBV infection as evidenced by studying immunosuppressed patients. CD8 T cells 
(known as effecter cells) provide the cytotoxic response, contain perforin and can secrete 
inflammatory cytokines upon activation in vitro in order to kill target cells (Callan, Fazou et al. 
2000). T cells can only see pathogens when peptides derived from the pathogen have been 
processed and presented to them via major histocompatibility complex (MHC) termed human 
leukocyte antigen (HLA) in humans. CD8+ T cells see peptide presented by MHC class I and each 
peptide sequence is specific to the pathogen it originates from and is restricted to the HLA type of 
the host and thus creates a highly specific immune response. 
1.4 EBV targets of the T cell response. 
 
Targets of the T cell response can be derived from proteins expressed from lytic and latent proteins. 
Overall, lytic replication occurs in three phases starting with the production of immediate early 
proteins (IE), BZLF1 and BRLF1, which activate a cascade of gene expression resulting in 
production of early proteins (E) and late proteins (L) and induce strong CD8+ responses(Hislop, 
Taylor et al. 2007). Latent infection manifests in B cell memory pools resulting in the expression of 
8 latent viral proteins with CD8+ T cells targeting the EBNA 3 family in preference over other 
latent proteins. The identification of different CD8+ T cell targets has helped develop successful 
immunotherapy, PTLD for example can be cured via the adoptive transfer of HLA matched  
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PBMCs enriched in the EBNA 3A,3B and 3C specific CD8+ T cells (Heslop, Ng et al. 1996; 
Khanna, Bell et al. 1999) The identification of new EBV epitopes is important in the development 
of future immunotherapy of other EBV associated diseases. 
1.5 Anatomy of the tonsil. 
 
The tonsil is a secondary lymphoid organ and is thought to be of particular use in the defence 
against pathogens invading the oropharynx. The tonsil is not fully encapsulated and the epithelium 
that is exposed to the throat contains a tough stratified squamous epithelium which is underlined by 
a layer of connective tissue protecting it from its external environment. The outer surface folds in 
on itself and forms tonsillar crypts which act as a passage to capture antigen from the pharyngeal 
lumen. In contrast, the tonsillar crypts contain sponge like epithelia and show a lack of a thick 
connective tissue band known as the lymphoepithelium. Direct antigen stimulation occurs here 
between antigens from the oropharynx and lymphocytes of the tonsil. Follicles are present through 
out the tonsil and are arranged parallel to the crypts.  The outer layer of the follicle is the follicular 
mantle which contains small lymphocytes beneath which lies the germinal centres (GC) formed for 
the purpose of  B cell maturation. GC's contain dark zones, containing blast cells, and light zones, 
which are packed with antigen presenting cells (APC). Between and below the follicular mantle is 
the T zone containing high endothelial venules enabling T lymphocytes to migrate from the blood 
to the lymphatic system (Figure 1.2). The structure and cell population of the tonsil enables it to be 
an efficient immune competent organ. 
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Figure 1.2 Schematic representation of tonsil structure. The exposed outer epithelium is an encapsulated, stratified 
squamous epithelium set upon a layer of connective tissue. The tonsillar crypts are not encapsulated and lack the 
connective tissue layer. Instead a sponge like structure can be seen containing a mixture of epithelial cells, lymphocytes 
and blood vessels forming the lymphoepithelium. The germinal centres are aligned parallel to the tonsillar crypts 
containing light and dark zones. (Perry and Whyte 1998) 
  
1.6 Tetramer Technology 
 
Since its introduction in 1996 (Altman, Moss et al. 1996) the use of soluble MHC class I tetramers 
has allowed for the in depth analysis of CD8+ T cells in terms of specificity, frequency and 
phenotype in a wide range of diseases. Activation of T cells specific for an antigen occurs through 
the interaction between MHC class I and TCR, however this is a weak interaction. Conventional 
MHC class I tetramers consist of 4 biotinylated MHC class I molecules lacking a transmembrane 
domain bound to a fluorochrome conjugated to streptavidin (Figure 1.3a). This complex act as a 
soluble probe for specific TCR’s with the 4 MHC molecules on a tetramer resenting the same 
peptide. This allows for binding to multiple TCR and therefore slows the dissociation rate of the 
TCR-MHC interaction(Altman, Moss et al. 1996). The fluorescence can be monitored by flow 
cytometry and have been used to discover frequencies of CD8+ T cells in hosts.CD8+ tetramer 
stained cells have been sorted and used in cytotoxicity and proliferation assays, their apoptotic 
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potential can be determined and by co-staining with other antibodies allows for the discovery of  T 
cell homing phenotypes  (Appay and Rowland-Jones 2002).  
The use of tetramers in investigating EBV biology has revealed more about EBV-specific T cell 
numbers as well as their  phenotype. Past studies have shown EBV infected healthy carriers contain 
significantly higher frequencies of EBV-specific CD8+ T cells, up to 20%, in the tonsil as 
compared to the peripheral blood of the same individual(Hislop, Kuo et al. 2005). Co-staining of 
tetramer positive CD8+ T cells have shown the EBV-specific CD8+ T cells in the tonsil have 
increased expression of CD103, an integrin associated with retention in mucosal 
epithelium(Woodberry, Suscovich et al. 2005). This suggests the tonsil epithelium as a potential site 
of viral infection and looking at the localisation of EBV-specific CD8+ T cells may uncover more 
about EBV biology. 
 
1.7 In situ Tetramer staining. 
 
Tetramer technology can now be adapted to look at the localization of these specific T cells in 
tissue. Skinner et al successfully developed the use of tetramers in tissue and were able to visualise, 
in mouse spleens, peptide specific CD8+ T cells, whose numbers were comparable to flow 
cytometry data(Skinner, Daniels et al. 2000). The optimisation of this technique has enabled for the 
identification of virus-specific CD8+ T cells and also be combined with techniques to identify cells 
infected with the target virus and discover the spatial relationships between viral replication and the 
CD8+ responses in situ(Bauquet, Jin et al. 2009; Li, Skinner et al. 2009). This protocol has since 
been used to look other chronic virus infections, from Simian Immunodeficiency Virus (Reynolds, 
Rakasz et al. 2005) to Herpes Simplex Virus - 2(Zhu, Koelle et al. 2007). Indirect in situ staining 
relies on amplification of tetramer signal (Skinner, Daniels et al. 2000) however direct tetramer 
staining methods using different fluorochromes have been used(Haanen, van Oijen et al. 2000). The 
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direct method allows for the visualisation of low frequency antigen specific CD8 cells without the 
problem of background fluorescence.  
 
 
 
Figure 1.3 Structure of Conventional Tetramer and Qdot Multimer. (a) A conventional, fluorescently labelled 
tetramer, which contains one strepatvidin molecule conjugated to a fluorochrome. Up to 4 biotinylated MHC class I 
monomers can be bound to a streptavidin molecule. (b) Qdot conjugated multimer – Qdot nanocrystal core is protected 
by an outer shell and polymer coating which has 5-10 streptavidin molecules attached. Each steptavidin molecule can 
have up 4 biontinylated  MHC class I molecules resulting in each Qdot molecule with a potential 20-40 MHC class I 
molecules attached. The increased MHC molecules on the Qdot multimer results in stronger binding.  
 
1.8 Qdot Multimer technology. 
 
Quantum dots (Qdots) are fluorophore nanocrystals which are extremely resilient to photo 
bleaching having a broad absorption spectra, with optimum absorption at UV wavelengths, but with 
narrow emission peaks (Figure 1.4) preventing bleed through into other fluorophore spectra and 
therefore make excellent tools in co staining experiments(Deerinck 2008). Qdots can be conjugated 
to streptavidin and upon addition of biotinylated MHC class I molecules can create Qdot multimers 
(Figure 1.3b). The multiple MHC class I monomers (a potential of 20-40 per Qdot) should therefore 
bind with more TCR potentially strengthening the interaction between TCR-MHC even more than 
MHC 
class I 
monomer 
Biotin 
Fluorescently 
labelled 
Streptavidin 
4 MHC  
class-I to 
each 
Streptavidin 
Qdot nanocrystal – core,  
shell, polymer coating  
 
a) Conventional  Fluorescently 
labelled Tetramer 
b) Qdot conjugated Multimer 
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conventional tetramers (Altman, Moss et al. 1996). These Qdot Multimers have proved to be 
successful in the detection of low frequency CD8+ T cells specific for HSV-2 in skin biopsies with 
all the advantages of direct in situ staining and the photo stability of these nanocrystals(Zhu, Koelle 
et al. 2007). 
 
Figure 1.4 Emission spectra of Qdot dyes(Chattopadhyay, Perfetto et al. 2010) 
1.9 Aims 
 
 This project aims to utilise Qdot multimer technology in in situ staining of human tonsil sections 
from healthy carriers. The high proportion of EBV-specific CD8+ T cells in the tonsil compared to 
the peripheral blood insinuates an importance of the tonsil as an EBV harbouring organ and a 
potential EBV replication site. The localization of these EBV-specific CD8+ T cells within the 
tonsil may reveal more about the immune regulation of EBV but also reveal the locations of cells 
replicating EBV in which the T cells target. 
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2 MATERIALS AND METHODS. 
 
2.1 Human tissue specimens and PBMCs. 
Eight tonsil specimens (each containing two whole tonsils) were collected from either the 
Birmingham Children’s Hospital NHS trust or University hospital of Birmingham NHS trust with 
all ethical considerations approved. Consent was taken from each patient and stored in the patient 
notes. Neither the HLA type nor the EBV status was known at the time of collection. One of the 
tonsils was cut into 0.5 x 0.5cm pieces and embedded in 4% Agarose and sectioned via vibratome 
to 200µm thick sections and used immediately for Immunofluorescence staining. The other tonsils 
were homogenised manually with a scalpel and the unfractionated mononucleocytes (UMs) 
separated by Lymphoprep (AXIS – SHIELD). The harvested cells were then either used for flow 
cytometry or stored in liquid nitrogen. Whole blood (60ml) was taken from healthy lab donors and 
PBMCs were separated with Lymphoprep (AXIS-SHIELD) and used in either flow cytometry or 
stored in liquid nitrogen.  
2.2 T cell clones 
T cell clones, previously established with a defined specificity, were removed from liquid nitrogen 
and activated with buffy coat cells and incubated at 37ºC for 10-14 days. After activation the clones 
were then fed twice weekly with T cell cloning media (10% foetal calf serum, 1% human serum, 
30% MLA, 1% penicillin/streptomycin, 50µl/ml IL2 and 58% RPMI)  and kept at 37ºC. The clones 
used were B8 FLR 213, B8 FLR IM59.1, A2 GLC IM225.8 and A2 YVL IM226. 
 
2.3 Synthesis of Qdot multimers and PE tetramers. 
MHC class I – EBV peptide biotinylated monomers were made previous to these experiments. A2 
restricted EBV peptide GLC and B8 restricted EBV peptide RAK and FLR biotinylated monomers 
were used to saturate streptavidin conjugated Qdot 655 (StpQdot655) (Invitrogen) via hourly 
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additions of saturating amount of monomer to a predetermined volume of StpQdot655, forming 
GLC-Q, RAK-Q and FLR-Q. For the conventional streptavidin conjugated PE (Invitrogen) 
tetramers hourly additions of streptavidin conjugated PE was added to a predetermined volume of 
monomer, forming GLC-PE, RAK-PE and FLR-Q.  
 
2.4 Staining of T cell clones for microscopic analysis. 
0.2 x10
6
 T cell clones were stained with either mouse anti human CD8-Qdot 655 (Invitrogen 
1:100), mouse anti IgG2a -Qdot 655 (Invitrogen 1:100), human CD8 purified antibody (Invitrogen 
1:100) or FITC mouse anti human CD8 (BD biosciences 1:50), purified mouse anti IgG2a k (BD 
Biosciences 1:100) or FITC mouse anti IgG2a k (BD Biosciences 1:50) for 30mins on ice  or Qdot 
multimer (1:25 GLC-Q, FLR-Q) for 15mins at 37ºC. Qdot multimer was added first in co-staining 
experiments and cells washed before the addition of co-staining antibody. Donkey anti human 
Alexa 488 (Invitrogen 1:100) was used as a secondary antibody in experiments using human CD8 
purified antibody as a primary antibody. 10µl of stained cells was then air dried onto a microscope 
slide and fixed in 50% acetone/ 50% methanol for 20mins at -20ºC. The slides were then washed in 
PBS and mounted with DABCO for viewing by confocal or epifluorescence microscopy. 
 
2.5 Immunofluorescence in situ staining of Tonsil 
Fresh 200µm thick tonsil sections were stained over night with either mouse anti human CD8-Qdot 
655 (Invitrogen 1:200), mouse anti IgG2a -Qdot 655 (Invitrogen 1:200), human CD8 purified 
antibody (Invitrogen 1:200) or FITC mouse anti human CD8 (BD biosciences 1:20), purified mouse 
anti IgG2a k (BD Biosciences 1:200) or FITC mouse anti human CD20 (BD biosciences 1:20) or 
Qdot multimer (1:50 RAK-Q, GLC-Q, FLR-Q) at 4ºC on a rocking platform. For co-staining of 
tissue human CD8 purified antibody was added alongside Qdot multimer in the initial overnight 
incubation. Tissues were then washed in MACS buffer and fixed in 4% paraformaldehyde for 
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30mins at room temperature. The sections were then washed and incubated with donkey anti mouse 
Alexa Fluor 488 (Invitrogen 1:200) (if required) for 1 hour at 4ºC on a rocking platform. Sections 
were then washed and mounted onto a microscope slide and mounted in DABCO for viewing with 
confocal or epifluorescence microscopy. 
 
2.6 Confocal and Epifluorescence microscopy 
Samples stained Qdot 655 reagents were viewed by epifluorescence microscopy (Nikon E600) 
using the Texas red filter set and FITC was viewed by the green filter set. Confocal Microscopy was 
carried out using the Zeiss Axiovert 200m.  Fluorescent dyes were excited by the following lasers: 
Qdot655 excited with Enterprise364nm and Alexa488 with Argon 488. A single track configuration 
was used with an NFT545 beam splitter with 505 Long Past (LP) filter for Alexa 488 and a 650 LP 
for Qdot 655. 
   
2.7 Flow cytometry 
T cell clones (0.1x10
6), tonsil UM’s (1 x106) and PBMCs (0.5 x106) were used in each flow 
cytometry experiment where relevant. The flow cytometers used were the XL-MCL for PE-
tetramers and the LSR II for Qdot multimers. Cells were stained with PE tetramer (1:50 FLR-PE, 
GLC-PE or RAK-PE) or Qdot multimer (1:50 GLC-Q, FLR-Q) for 15mins at 37ºC. Cells stained 
with Qdot multimer were then co stained with PE mouse anti human CD8 (1:40 BD Biosciences) 
cells stained with PE tetramer were co stained with Human CD8 Tri Colour conjugate (1/40 
Invitrogen) for 30mins on ice. Cells are then washed and resuspended in PBS (2% fcs) and analysed 
by flow cytometry.  
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3 RESULTS. 
 
3.1 Determination of the amount of MHC class I monomer required to be added 1µl of 1µM 
Qdot 655 to achieve optimal staining of a T cell clone with this reagent 
Few studies have been conducted using Qdot reagents as fluorochromes bound to MHC class I 
multimers for staining T cells.  It is unclear what amount of class I molecule should be added to the 
Qdot streptavidin that allows stable binding to T cell receptors without causing non-specific 
binding.  As such, an empirical experiment was conducted in which different amounts of an HLA 
A2 monomer was titrated onto a constant amount of Streptavidin conjugated Qdot 655 
(StpQdot655) and these reagents were then used to stain specific T cell clones and analysed by flow 
cytometry. Here monomers containing the GLC peptide from the EBV BMLF1 protein were used 
and tested against a cognate T cell clone IM225.8. StpQdot655 (1pmol) was mixed with 
either1.3ug, 2.6ug, 3.9ug, 5.2ug or 6.5ug of GLC monomer. Flow cytometry analysis of the clones 
stained with the GLC Qdot multimer (GLC-Q) and anti-CD8 antibodies suggested that mixing 
3.9ug of HLA class I protein with 1pmol of StpQdot655, gave the clearest staining in that the 
population of cells stained the brightest with the least amount of background staining (Figure 3.1). 
In future experiments Qdot multimers were made at a ratio of 3.9ug monomer to 1pmol of 
StpQdot655. 
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Figure 3.2 Saturation of Streptavidin conjugated Qdot with A2 GLC monomer. 
Frequency of GLC-specific CD8+ T cells in (A) a GLC-specific clone or (B) an irrelevant HLA A2 restricted YVL-
specific clone. Clones were stained with GLC-Q and further stained with anti-CD8 mAbs. The results shown have been 
gated on CD8 + cells. Values shown refer to the percentage of CD8+ cells stained with Qdot multimer.  
 
 
 
3.2 Validation and titration of GLC Qdot vs. PBMCs from HLA A2EBV sero positive and sero 
negative donors and a GLC-specific T cell clone. 
In order to further validate the GLC-Q reagent made under the optimal conditions determined 
above, this reagent was tested against the same GLC T cell clone for consistency. A new batch of 
GLC-Q was made at a concentration of 3.9ug monomer to 1pmol of StpQdot655 and was also 
tested against the GLC T cell clone as well as an HLA A2 EBV seropositive donor PBMCs to test 
the ability to bind to resting GLC-specific T cells and an HLA A2 EBV seronegative donor 
PBMC’s to determine background staining. The GLC-Q was titrated at 1/25, 1/50 and 1/100 
dilutions on the above cell types in parallel experiments. The new batch of GLC-Q showed 
comparable results to the original batch of GLC-Q against IM225.8 GLC clones (Figure 3.2a) 
showing consistency between the batches. Interestingly, at higher concentrations of GLC-Q an 
increase in double negative GLC clone populations was seen (Figure 3.2a).  The lower 
concentrations of the GLC-Q showed less fluorescence intensity, giving an apparent reduction in 
GLC 
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GLC  
6.5ug 
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GLC Q 
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CLO
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the CD8+ clonal population specific for GLC to 91.46%. This was shown in the EBV seropositive 
donor and again a titration effect of decreasing intensity and percentage positivity was observed 
with decreasing concentration of the GLC-Q multimer (Figure 3.2b).  At lower dilutions it was 
difficult to separate discrete populations of GLC positive cells from the multimer negative cells in 
the seropositive donor due to the low intensity staining.  PBMCs from the seronegative donor 
showed no GLC-Q staining at all concentrations tested thus showing the absence of EBV derived 
GLC-specific T cells in the peripheral circulation (figure 3.2c). The absence of GLC-Q staining 
cells in the seronegative donor was consistent with the specificity data of GLC-Q staining against 
an irrelevant YVL clone (Figure 3.1b) confirming the GLC-Q was extremely specific and does not 
non-specifically bind to other cells. Interestingly, the high concentration of GLC-Q did not 
substantially increase the double negative population of PBMCs when tested against the 
seropositive and seronegative donors, suggesting this phenomenon was specific to the highly 
activated GLC clone. Due to the effect of higher concentrations of GLC-Q increasing the double 
negative population and the less intense fluorescence seen at lower concentration all flow cytometry 
Qdot multimer experiments was performed using a 1/50 dilution.   
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Figure 3.2. Frequency of EBV-specific CD8+ T cells in (a) GLC clone IM225.8, (b) PBMC’s of a Sero positive 
donor and (c) PBMCs of a Sero negative donor.  
GLC clones were stained with either 1/25, 1/50 or 1/100 dilutions of GLC loaded Qdot multimers (GLC-Q) and 
further stained with anti-CD8 mAbs. GLC clones and PBMCs were gated on the lymphocyte population. Values 
shown refer to the percentage of CD8+ cells stained with Qdot multimer.  
1/25 1/50 1/100 
Old batch 
GLC-Q 1/50 
CD8 
(a) 
 
GLC  
clone 
IM225.8 
(b) 
 
EBV 
sero 
positive 
 
(c) 
 
EBV 
sero  
negative 
 
18 
 
3.3 Validation of Qdot multimer versus conventional PE tetramer staining of tonsillar 
Unfractionated Mononuclear (UM) populations. 
In the next series of experiments, the capability of Q-dot multimers to detect the same frequency of 
EBV peptide-specific CD8+ T cells was compared to conventional Class I MHC tetramers in 
tonsillar UM populations by flow cytometry.  To conduct this work additional Qdot multimers were 
made using the conditions determined above.  Here HLA B8 monomers were made containing the 
HLA B8 presented peptides either RAK or FLR, from BZLF1 or EBNA3A, giving additional 
reagents to A2 GLC-Q for use in subsequent experiments. These new reagents were validated as 
described above (data not shown).   
Tonsil 26 (T26) UM’s was known to have relatively high numbers of CD8+ T cells specific for 
FLR (Hislop, Kuo et al. 2005) and were stained with FLR-Q multimer or a conventional FLR 
tetramer labelled with phycoerythrin (PE) and co stained with CD8 antibody. As a control, a culture 
of cells known to have FLR-specific cells present (IM63.1) was also stained with these reagents. 
Figure 3.3 shows that the FLR-PE and FLR-Q tested on FLR cells showed comparable results of 
2.83% positive with FLR-PE and 2.96% positive with FLR-Q. Analysis of the T26 UMs showed a 
frequency of 5.3% of CD8+ T cells stained positive with FLR-Q and FLR-PE (Figure 3.3). The 
fluorescence intensity shown when staining T26 UMs was remarkably less bright compared to the 
FLR culture. The comparable results allows for the confidence of the use of Qdot multimers to stain 
for CD8+-T cells specific for EBV peptides in tonsils and is also comparable to conventional 
tetramer. 
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3.4 Epifluorescence analysis of GLC-specific clone staining using the Qdot multimer. 
It was important to determine whether these Qdot multimers could be visualised by microscopic, 
and later, confocal analysis. GLC-specific clones were firstly stained with either directly conjugated 
anti-CD8-Qdot655 (CD8-Q) or CD8-FITC alone, GLC-Q alone or the combination of GLC-Q and 
CD8-FITC. The stained cells were then dried onto microscope slides, fixed using acetone/methanol 
and mounted with DABCO before viewing under the epifluorescent microscope. Firstly the clones 
stained with CD8-Q were viewed in order to determine if the microscope filters could detect the 
Qdot655 emission. Using the Texas red emission filter (600-650nm), overlapping with the emission 
of Qdot655 (600-700nm – figure 1.3), GLC clones stained for CD8-Q showed clear staining (Figure 
3.4a). CD8-FITC staining alone of GLC clones was viewed under the FITC filter of the microscope 
(Figure 3.4b). The use of an isotype control (IgG2a) showed little non specific binding and cells 
stained with CD8-FITC can easily be distinguished from background staining (Figure 3.4b). Next, 
GLC clones stained with GLC-Q alone were viewed using the same settings as for CD8-Q. Using 
Figure 3.3 Validation of Qdot and PE tetramers vs. Tonsil Sample T26. FLR-PE and FLR-Q multimer 
stained T26 Unfractionated Mononuclear cells (UM) and FLR clones IM63.1. T26 UM and IM631 cells were 
stained with either FLR-Q multimer or FLR-PE tetramer and further stained for with CD8 conjugated 
antibody. The lymphocyte population was gated and the percentages shown refer to the percentage CD8 T 
cells which show FLR peptide specificity. 
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these cells and GLC-Q combination, GLC-Q staining could be easily visualised (Figure 3.4c). To 
test for non specific staining, the GLC-Q was also used on an irrelevant YVL-specific clone. No 
fluorescence could be seen (Figure 3.4c), indicating that any fluorescence seen by the GLC-Q on 
the GLC clone is specific.  As the ultimate goal for this project is to use the Qdot655 multimers 
alongside a T cell marker (CD8-FITC) for in situ staining, clones were stained with both GLC-Q 
and CD8-FITC and analysed by visualising using the FITC and Texas red filter sets. Figure 3.4d 
shows that cells that fluoresce for GLC-Q under the Texas red filter also fluoresce for CD8-FITC 
under the FITC filter. This result allows confidence in the use of GLC-Q in microscopic analysis 
and appropriately stained EBV-specific CD8 positive cells could be viewed using the combination 
of EBV specific peptide Qdot655 multimer and CD8-FITC co-stain. 
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Figure 3.4 – Epifluorescence microscopy of GLC clones. Stained with fluorescently labelled CD8 antibody alone (a 
& b), GLC-Q alone against GLC clones and YVL clones (c) or   combined GLC-Q and anti CD8-FITC antibody 
staining on GLC clones (d). 
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3.5 Tissue staining with Qdot655 multimer, anti-CD8 and anti-CD20 and analysis by 
epifluorescence microscopy. 
As the fluorochromes FITC and Qdot655 had been validated for use on the epifluorescence 
microscope, Qdot655 multimers were tested by conducting in situ tissue staining of a fresh 
tonsillectomy specimen (T43). T43 was sliced using a scalpel into thin sections and individual 
pieces stained overnight with, CD8-FITC, CD8-Q, GLC-Q alone or CD20-FITC. CD20 is an 
activation marker found on B cells, a prominent cell type within the tonsil due to presence of 
germinal centres. This staining was undertaken to give some anatomical context as to where cell 
types other than CD8+s could be found. The slices were then fixed and mounted on a microscope 
slide with DABCO and viewed under the epifluorescence microscope.  
The first observation was that the tissue sections were too thick to view individual cells or tonsil 
structure under the epifluorescence microscope and it was only at the edges of the tissue sections 
which were thinner that cells could be seen either on bright field or UV light settings. CD20 
staining of sections indicated a relatively high abundance of CD20 cells within the section stained 
as expected for a tonsil tissue (Figure 3.5a). However the CD8+T cells were more difficult to find 
within the tissue slice and were not frequent in areas where single cells could be viewed. However, 
those cells that fluoresced with CD8-FITC and CD8-Q were obvious compared with background 
staining seen throughout the tissue (Figure 3.5a).  CD8-FITC became less bright overtime whilst the 
CD8-Q staining remained bright and appeared to be a more stable fluorophore. T43 was also stained 
with GLC-Q alone, however no fluorescence was seen when multiple fields of view were examined 
(Figure 3.5a). To confirm the absence of GLC-specific CD8+ T cells within the tonsil, a single cell 
homogenate of T43 made at the time of sectioning was subjected to conventional GLC-PE tetramer 
staining, analysed via flow cytometry gating on the lymphocyte population (Figure 3.5b). T43 
showed a CD8+ frequency of 3.91% of the total lymphocyte population of which none were GLC-
PE tetramer positive; this supports the microscope findings in Figure 3.5a.  This demonstrates that 
using these reagents on such tissue sections gave low background staining.  However given the low 
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percentage of CD8+ T cells within T43 and also the fact that most of the tissue was too thick to 
view individual cells clearly meant that an alternative method to viewing thick tissue would be 
more successful and so attentions turned towards using confocal microscopy.  
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Figure 3.5 – In-situ tissue staining of Tonsil (T43) and Flow cytometry GLC-PE tetramer 
staining of T43 UM’s  
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3.6 Optimisation of Confocal Microscopy using T cell clones stained with Qdot655 and 
Alexa488 labelled antibodies. 
 
In order to ensure the correct laser and filter sets were in place on the confocal microscope GLC-
specific clones were firstly stained with either CD8 conjugated to FITC (CD8-FITC) or CD8 
conjugated to Qdot655 (CD8-Q). GLC IM225.8 T cell clones were stained individually with these 
reagents, fixed onto microscope slides and mounted with DABCO. FITC is excited at a wavelength 
of 488nm and emits at a wavelength of 525nm, the 488 laser was therefore used to excite and a 
505LP green filter was used to capture emission. The CD8-FITC antibody was generally not stable 
enough for longer exposures as although staining was seen it quickly became photo bleached by the 
488 laser and images deteriorated before they could be captured (Figure 3.6a).  
In a second series of optimisation experiments an alternative fluorophore was sought that would not 
photo bleach under the 488 laser and so Alexa fluor 488 (Alexa488), which is a more stable 
equivalent to FITC, was used. The Alexa488 conjugated secondary antibody used was in 
conjunction with an anti MHC class I primary antibody against the GLC-specific clones.  This 
fluorchrome proved to be more photo stable and gave clear staining of GLC clones (Figure 3.6b). 
The optimum excitation of Qdot655 nanocrystals is 364 nm and emits at 655 nm and so the CD8-Q 
could be viewed using the UV laser with a 650 LP red filter which let light with a wavelength of 
>650nm pass through and fluoresces red upon excitation and gave clear staining of GLC 
clones(Figure 3. 6a & b). GLC clones were also co-stained for class I and  CD8 using the same 
reagents and the use of the 488 laser and the UV laser together with the correct filters (red and 
green) allowed for cells expressing Class I and CD8 to be viewed (Figure 3.6b). These results 
confirmed the settings on the confocal microscope were now in place in order to view Qdot655 and 
Alexa488 fluorochromes as a co-stain marker (Figure 3.6b). 
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Figure 3.6 – Confocal images of GLC clones stained with different excitation fluorochromes. (a) GLC clones 
IM225.8 stained with CD8 FITC or CD8-Q. CD8-FITC deteriorated under the 488 laser and staining was not clear. 
CD8-Q staining remained strong and extracellular staining could be seen in red. (b) GLC clones IM225.8 with class I 
Alexa 488 (green) co stained with CD8-Q (red) and mounted with DABCO. 
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3.7 Determining if the Qdot multimers can be viewed using the optimised confocal 
configuration.  
It was vital to determine the Qdot655 multimers could also be viewed along side CD8-Alexa488. In 
this series of experiments FLR-specific clones were firstly stained with CD8-Q or an unlabelled 
CD8-specific antibody followed by the anti-mouse-Alexa488 antibody and fixed onto slides in 
order to validate the confocal configuration. Figure 3.7a shows clear staining of the CD8-Alexa488 
and staining with isotype matched control antibodies in parallel showed no background staining. 
Figure 3.7b also showed clear staining with the CD8-Q of the FLR clones and showed absence of 
staining when using the isotype matched control. An aliquot of FLR-specific clones were also 
stained with FLR-Q alone and under the same configuration showed fluorescence of the FLR-Q in 
the red channel (Figure 3 7c) although it was not a bright as the CD8-Q staining (Figure 3.7b).  
Finally the clones were co-stained with FLR-Q and CD8-Alexa488, were fixed and viewed under 
the confocal microscope. Figure 3.7d shows FLR-specific clones stained positive for CD8-
Alexa488 (green) and those same cells also stained positive for FLR-Q (red) and could be viewed 
under this confocal configuration. Furthermore when an irrelevant T cell clone (GLC IM225.8) was 
stained with CD8-Alexa488 and FLR-Q, the clones only stained postive for CD8 (green), and 
showed no staining of FLR-Q (red) thus confirming the specificity of the multimer. This gave 
confidence in the ability to view CD8+ T cells specific for EBV peptides the Qdot multimers 
present in tissue sections under these microscope settings. 
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Figure 3.7 – Confocal images of FLR-Q, CD8-Alexa488 and CD8-Q staining using FLR clones.  FLR clones were 
stained with CD8-Alexa488 alone (a) CD8-Q alone (b) FLR-Q alone (c) and with the combination of CD8-Alexa488 
and FLR-Q or irrelevant GLC-Q (d). 
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3.8 In situ staining of tonsil sections with Qdot multimers and confocal imaging. 
In the final series of experiments a fresh tonsil was collected for sectioning and staining with Qdot 
multimers.  Firstly to determine if any GLC- or FLR-specific CD8+ T cells were present in the T48 
tonsil flow cytometry analysis was performed on a homogenised sample of the tonsil an stained 
with GLC-PE or FLR-PE tetramers followed by anti-CD8. This analysis showed a cluster of cells 
appeared when GLC-PE tetramer was used and accounted for 0.28% of the CD8+ population, 
however in the presence of FLR-PE no cluster could be seen (Figure 3.8).  
 
Figure 3.8 – Flow cytometry analysis of T48 UMs. Staining of T48 UM’s with GLC-PE and FLR – PE tetramer. 
Percentage represents the number of CD8+ cells stained positive for tetramer. 
 
 
 
 
 
 
 
 
 
 
 
 
As before, the remainder of the tonsil was sliced into 200µm sections using a vibratome and these 
were stained overnight with either unlabelled anti-CD8 followed by anti-mouse 488, or CD8-Q 
alone, or with Qdot multimer alone (FLR-Q or GLC-Q), or with Qdot multimer and unlabelled anti 
CD8 antibody followed by anti-mouse Alexa488 co-stain. The sections were then fixed, mounted 
with DABCO and viewed by confocal microscopy. Firstly, CD8-Alexa488 staining (green) could be 
distinguished in spite of more background fluorescence of the tissue in the presence of CD8-
Alexa488 (Figure 3.9a). Interestingly, the CD8-Alexa488 positive cells appeared to be found in 
clusters towards the outer edge (Figure 3.9a) of the tissue and less frequently in the centre of the 
tissue, however without any other anatomical landmark staining the importance of this was 
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unknown (Figure 3.9b). The absence of staining in the presence of isotype-Alexa488 (Figure 3.9c) 
indicates specific binding of the CD8-Alexa488 antibody (Figure 3.9a).  
T48 was also stained with CD8-Q in order to ensure Qdot655 multimers would be able to be 
visualised in tissue under the current confocal configuration. CD8-Q stained cells were clearly 
visualised in the T48 sections (Figure 3.9d) however the same distribution of CD8-Q stained cells 
was seen as before with the CD8-Alexa488, showing to be more frequent towards the edge of the 
tissue compared with the centre along the same focal plane (Figure 3.9e). Isotype matched IgG2a 
Qdot655 antibody showed no staining within the T48 sections showing the specific binding of 
CD8-Q (Figure 3.9f).  
Next, the sections that were stained with A2 GLC-Q or B8 FLR–Q were viewed to look for any 
CD8+ T cells specific for these two EBV derived peptides. Confocal microscopy revealed although 
CD8-Alexa488 stained T cells could be seen, none of these CD8-Alexa488 positive cells showed co 
staining with GLC-Q or FLR-Q in the multiple fields viewed (Figure 3.10c & d). In other sections 
from the same tonsil FLR-Q and GLC-Q were used alone to eliminate any interference that may be 
caused by the CD8-Alexa488 and again no GLC-Q or FLR-Q positive cells could be seen verifying 
the lack of CD8+ T cells staining for multimer (Figure 3.10 a &b).The low frequency of GLC 
specific CD8+ T cells in the flow data (Figure 3.8) where approximately 7% of UMs were CD8 
positive could account for the lack of GLC-Q positive cells in the tissue section that was stained 
(Figure 3.9b).   
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Figure 3.9 – Confocal images, validating Alexa488 and Qdot655 reagents for use in in-situ staining of the tonsil 
(T48). T48 sections were individually stained with anti CD8 antibodies or isotype control conjugated with Alexa488 
(a,b + c) or with Qdot655 reagents (d,e +f). 
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Figure 3.10 – confocal images of combined antibody and tetramer in situ staining of T48. T48 was stained with 
FLR-Q alone (a) GLC-Q alone (b) and combination staining with CD8-Alexa488 and either FLR-Q (c) or GLC-Q (d). 
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4 DISCUSSION 
 
Hislop et.al 2005 and Woodberry et.al 2005 previously discovered that the human tonsil harbours 
high amounts of EBV-specific CD8+ T cells compared to the peripheral blood of healthy EBV 
infected carriers. This has led to the aims of this project to discover the localisation of these EBV-
specific CD8+ T cells within the tonsil. Tetramer technology has been adapted for use in, in situ 
tissue staining and has allowed the visualisation of virus-specific CD8+ T cells in tissue (Skinner, 
Daniels et al. 2000) and has also enabled the discovery of T cell localisation and interactions of 
virus-specific CD8+  T cells with surrounding tissue cells(Zhu, Koelle et al. 2007; Hong, Reynolds 
et al. 2009). Tetramers are shown to work best in fresh tissue and using them in direct staining 
reduces background fluorescence (Haanen, van Oijen et al. 2000). Therefore, direct tetramer 
staining of fresh tonsil tissue was to be implemented in this project but, before this can be achieved 
much validation and problem solving was performed. 
The tonsil proved to be a structurally tough organ due to a stratified squamous nonkeratinized 
epithelium which is underlined by a band of thick connective tissue (Perry and Whyte 1998). In 
contrast the lymphoepithelium,  which lines the tonsillar crypts and contains lymphocytes(Perry and 
Whyte 1998), can be described as quite spongy. The tough outer epithelium and spongy 
lymphoepithelium made slicing of fresh tonsil into thin enough slices for viewing structure as well 
as single T cells quite challenging. The tissue needed to be sliced into small sections (0.5cm/0.5cm), 
embedded in 4% agarose and kept chilled, maintaining the freshness of the tissue but also making 
the tonsil tissue more firm and therefore easier to cut. Even so it took many attempts with a 
vibratome to obtain satisfactory sections, often producing a limited number of sections mostly due 
to the elasticity of the tissue, which is extremely problematic for further use. In future studies an 
option may be to keep the tissue stored in PBS at 4˚C overnight which may make the tonsil tissue 
more rigid. This method has been done in past studies showing no difference in tetramer staining 
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compared to tissue that is stained shortly after sectioning (Skinner, Daniels et al. 2000) and prevents 
the interference of chemicals and maintaining the freshness of the tissue as much as possible. 
The generation of more tonsil sections would have made this project more feasible, but to account 
for the difficulties in slicing of the tonsil may mean it would have had to be processed in a different 
way. Snap freezing tissue proves unsuccessful for tetramer staining as this kills the cells (Skinner 
and Haase 2002). However staining small tissue sections with tetramer first before snap freezing 
and sectioning has been shown to provide sections with tetramer staining comparable to that of 
fresh sections (Vyth-Dreese, Kim et al. 2006) however cryosections of tissue are generally much 
thinner than fresh sections and cause problems in looking for low frequency T cells(Skinner, 
Daniels et al. 2000).  
Out of the 8 tonsils that were collected only 1, T48, showed a response to GLC tetramer by flow 
cytometry however this response was quite low at 0.28% of the total CD8+ which is only 7% of the 
total UM  population in T48. (Figure 3.8). This indicates that out of 5000 UM’s in the tonsil only 1 
will be a CD8+ T cell specific for  the EBV GLC-epitope, if these cells were homogenously 
distributed through the tissue. The fact that only a limited number of sections were obtained from 
one piece of tonsil dissected in which only two slices were stained with GLC-Q multimer, made the 
odds of discovering the low frequency of GLC-specific CD8+ T cells remote. It was therefore not 
so unexpected that the 0.28% GLC-specific CD8+ T cells could not be visualised by microscopy 
(Figure 3.10). However, it cannot be excluded that the staining protocol was not successful. In 
future experiments visualising other specificities, which maybe more in enriched in the patient, 
could be studied.  
The lack of medical history of the tonsil specimens collected throughout this study meant that the 
EBV status of the patient and whether the donor had responses to the epitopes used was unknown. 
Another complication was that the HLA type of the patient was also unknown at the time of 
staining. As such the multimer staining was done blindly using HLA A2 GLC, HLA B8 RAK and 
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HLA B8 FLR multimers. Furthermore, even if a patient was the correct HLA type and is EBV 
infected they may not necessarily mount a response to a known HLA restricted EBV peptide (Bihl, 
Frahm et al. 2006). As described above the small snapshot of tonsil viewed by microscopy can not 
provide the full picture and so the remainder of each tonsil collected was homogenised and the 
UM’s analysed by flow cytometry with the same peptide panel of tetramers/multimer. Flow data 
and in situ staining have been shown to be comparable (Skinner and Haase 2002) and one success 
of the Qdot655 multimers is a lack of non-specific binding as background levels were low in flow 
cytometry and microscopy experiments. It also revealed that the majority of tonsils collected in this 
project did not contain T cell specific to the tetramers tested and is consistent with the lack of 
multimer positive cell staining in the tissue (all data not shown). 
Qdot nanocrystals were used due to them characteristically being a more photo stable, brighter 
alternative to traditional fluorescent dyes (Chattopadhyay, Price et al. 2006) and can be conjugated 
to streptavidin and saturated with MHC class I to produce Qdot multimers for use in direct in situ 
staining. Zhu, et al 2007 have used Qdot multimers to identify the localisation of low frequency 
HSV-2 specific CD8+ T cells in skin lesions and prompted the use of Qdot multimers in this study 
to look at the localisation of EBV-specific CD8+ T cells in tonsil tissue. Validation experiments 
using flow cytometry show that although the Qdot655 multimers showed comparable specificity 
they did not appear to be much brighter in fluorescence intensity compared to conventional 
tetramers (Figure 3.3). When used on T cell clones to validate the use of the Qdot655 multimers in 
confocal microscopy, they did not appear very bright at all especially when compared to the CD8-Q 
counterpart perhaps reflecting the affinities with which these reagents bind to their ligands. 
The results in Figure 3.9 showed an apparent difference in CD8+ staining, more frequent at the 
edge of the tissue compared with the low frequencies in the centre of the tissue, along the same 
focal plane. The antibody not infiltrating the tissue effectively maybe a cause of this anomaly and 
only staining cells towards the edge of the tissue might be due to thinning of the tissue at the edges. 
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If this is the case, the same effects maybe seen with use of the Qdot655 multimers in tissue however 
this is all speculative. Validating the use of Qdot655 multimers in microscopy has been confirmed 
with the use of matched CD8+ T cell clones to Qdot655 multimers which have been an 
indispensible tool throughout the project.  
A limitation in using the Qdot655 multimer in in situ tissue staining is that its use in tissue could not 
be validated. One reason for this is the lack of a tonsil sections thin enough for analysis, but another 
reason is the lack of tonsil samples collected containing tetramer positive CD8+ T cells making it 
difficult to determine if the Qdot655 multimers produced would work in this staining protocol. 
Other groups have used TCR transgenic mice to ensure T cells expressing the matched TCR’s are 
present for the tetramers to bind(Skinner, Daniels et al. 2000), however this was not conceivable for 
this project. Future experiments maybe to incubate tonsil sections with T cell clones, relying on 
migration into the tonsil sections and then stain with the matched Qdot655 multimers.  
The use of EBV-specific T cell targeting tetramers in in-situ tissue staining can provide much more 
information about their localisation within tonsil tissue by co staining for other cells in the 
environment. It is still unclear if the EBV-specific CD8+ T cells are located near to the germinal 
centres of B cells or located near to Epithelium of the tonsillar crypts or tonsil surface. Once the 
tetramers have been optimised for use in tonsil tissue these questions will be answered. 
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